Status:
UNKNOWN
Prevention of Corticosteroid-induced Glucose Intolerance
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Glucose Intolerance
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intoleran...
Detailed Description
Glucose intolerance is frequent and serious complication of corticosteroid therapy. the aim of the study is to examine the hypothesis that co treatment with rosiglitazone can prevent glucose intoleran...
Eligibility Criteria
Inclusion
- corticosteroid treatment
Exclusion
- congestive heart failure pedal edema
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00240604
Start Date
April 1 2005
End Date
October 1 2015
Last Update
September 14 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91120